FOLH1 and metastatic malignant neoplasm in the lymph nodes: PSMA‐PET/CT identified metastases in 63/130 (48%), with 37/63 (59%) having lymph node metastases (LNMs) limited to the ePLND template – 16/37 (43%) on the ipsilateral side of the positive resected node.